Slow cortical potentials neurofeedback in children with ADHD: comorbidity, self-regulation and clinical outcomes 6 months after treatment in a multicenter randomized controlled trial.

Saved in:
Bibliographic Details
Title: Slow cortical potentials neurofeedback in children with ADHD: comorbidity, self-regulation and clinical outcomes 6 months after treatment in a multicenter randomized controlled trial.
Authors: Aggensteiner, Pascal-M., Brandeis, D., Millenet, S., Hohmann, S., Ruckes, C., Beuth, S., Albrecht, B., Schmitt, G., Schermuly, S., Wörz, S., Gevensleben, H., Freitag, C. M., Banaschewski, T., Rothenberger, A., Strehl, U., Holtmann, M.
Source: European Child & Adolescent Psychiatry. Aug2019, Vol. 28 Issue 8, p1087-1095. 9p. 1 Diagram, 3 Charts, 1 Graph.
Subjects: Treatment of attention-deficit hyperactivity disorder, Brain physiology, Attention-deficit hyperactivity disorder, Physiological control systems, Electromyography, Evoked potentials (Electrophysiology), Medical cooperation, Classification of mental disorders, Research, Self-management (Psychology), Comorbidity, Disease relapse, Effect sizes (Statistics), Randomized controlled trials, Treatment effectiveness, Pre-tests & post-tests, Children
Geographic Terms: Germany
Abstract: Despite sizeable short-term effects of neurofeedback (NF) therapy on attention-deficit and hyperactivity disorder (ADHD), longer-term clinical, comorbidity and self-regulation outcomes are less systematically studied. The aim of this largest NF follow-up to date was to evaluate these outcomes 6 months after NF compared to a semi-active control to disentangle specific from unspecific sustained effects. We performed a multicenter, randomized, parallel, controlled, clinical, superiority trial in five German university outpatient departments. Participants were eligible if they fulfilled DSM-IV-TR criteria for ADHD and were aged from 7 to 9 years. Participants were randomly assigned (1:1-ratio) to 25 sessions of slow cortical potential (SCP)-NF or electromyogram biofeedback (EMG-BF). Participants were not blinded, since they received instructions according to each treatment setting. Primary outcomes were parent ratings of ADHD. The trial was registered, number ISRCTN761871859. Both groups showed improvement of ADHD symptoms compared to baseline at 6-months follow-up with large effect sizes for SCP-NF (d = 1.04) and EMG-BF (d = 0.85), but without group differences. When analyzing all assessments (pre-test, post-test-1, post-test-2 and follow-up), a group-by-time interaction emerged (p = 0.0062), with SCP-NF showing stable improvement following treatment but EMG-BF showing a relapse from post-test-1 to post-test-2, and subsequent remission at follow-up. Six months after the end of treatment, improvement after SCP-NF remained large and stable. However, the lack of group differences at follow-up suggests shared specific and unspecific effects contributing to this clinical outcome. Our correlational results indicate specificity of SCP-NF for selected subscales after training, but not at follow-up. [ABSTRACT FROM AUTHOR]
Copyright of European Child & Adolescent Psychiatry is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 137848991
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Slow cortical potentials neurofeedback in children with ADHD: comorbidity, self-regulation and clinical outcomes 6 months after treatment in a multicenter randomized controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Aggensteiner%2C+Pascal-M%2E%22">Aggensteiner, Pascal-M.</searchLink><br /><searchLink fieldCode="AR" term="%22Brandeis%2C+D%2E%22">Brandeis, D.</searchLink><br /><searchLink fieldCode="AR" term="%22Millenet%2C+S%2E%22">Millenet, S.</searchLink><br /><searchLink fieldCode="AR" term="%22Hohmann%2C+S%2E%22">Hohmann, S.</searchLink><br /><searchLink fieldCode="AR" term="%22Ruckes%2C+C%2E%22">Ruckes, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Beuth%2C+S%2E%22">Beuth, S.</searchLink><br /><searchLink fieldCode="AR" term="%22Albrecht%2C+B%2E%22">Albrecht, B.</searchLink><br /><searchLink fieldCode="AR" term="%22Schmitt%2C+G%2E%22">Schmitt, G.</searchLink><br /><searchLink fieldCode="AR" term="%22Schermuly%2C+S%2E%22">Schermuly, S.</searchLink><br /><searchLink fieldCode="AR" term="%22Wörz%2C+S%2E%22">Wörz, S.</searchLink><br /><searchLink fieldCode="AR" term="%22Gevensleben%2C+H%2E%22">Gevensleben, H.</searchLink><br /><searchLink fieldCode="AR" term="%22Freitag%2C+C%2E+M%2E%22">Freitag, C. M.</searchLink><br /><searchLink fieldCode="AR" term="%22Banaschewski%2C+T%2E%22">Banaschewski, T.</searchLink><br /><searchLink fieldCode="AR" term="%22Rothenberger%2C+A%2E%22">Rothenberger, A.</searchLink><br /><searchLink fieldCode="AR" term="%22Strehl%2C+U%2E%22">Strehl, U.</searchLink><br /><searchLink fieldCode="AR" term="%22Holtmann%2C+M%2E%22">Holtmann, M.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22European+Child+%26+Adolescent+Psychiatry%22">European Child & Adolescent Psychiatry</searchLink>. Aug2019, Vol. 28 Issue 8, p1087-1095. 9p. 1 Diagram, 3 Charts, 1 Graph.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Treatment+of+attention-deficit+hyperactivity+disorder%22">Treatment of attention-deficit hyperactivity disorder</searchLink><br /><searchLink fieldCode="DE" term="%22Brain+physiology%22">Brain physiology</searchLink><br /><searchLink fieldCode="DE" term="%22Attention-deficit+hyperactivity+disorder%22">Attention-deficit hyperactivity disorder</searchLink><br /><searchLink fieldCode="DE" term="%22Physiological+control+systems%22">Physiological control systems</searchLink><br /><searchLink fieldCode="DE" term="%22Electromyography%22">Electromyography</searchLink><br /><searchLink fieldCode="DE" term="%22Evoked+potentials+%28Electrophysiology%29%22">Evoked potentials (Electrophysiology)</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+cooperation%22">Medical cooperation</searchLink><br /><searchLink fieldCode="DE" term="%22Classification+of+mental+disorders%22">Classification of mental disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Research%22">Research</searchLink><br /><searchLink fieldCode="DE" term="%22Self-management+%28Psychology%29%22">Self-management (Psychology)</searchLink><br /><searchLink fieldCode="DE" term="%22Comorbidity%22">Comorbidity</searchLink><br /><searchLink fieldCode="DE" term="%22Disease+relapse%22">Disease relapse</searchLink><br /><searchLink fieldCode="DE" term="%22Effect+sizes+%28Statistics%29%22">Effect sizes (Statistics)</searchLink><br /><searchLink fieldCode="DE" term="%22Randomized+controlled+trials%22">Randomized controlled trials</searchLink><br /><searchLink fieldCode="DE" term="%22Treatment+effectiveness%22">Treatment effectiveness</searchLink><br /><searchLink fieldCode="DE" term="%22Pre-tests+%26+post-tests%22">Pre-tests & post-tests</searchLink><br /><searchLink fieldCode="DE" term="%22Children%22">Children</searchLink>
– Name: SubjectGeographic
  Label: Geographic Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Germany%22">Germany</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Despite sizeable short-term effects of neurofeedback (NF) therapy on attention-deficit and hyperactivity disorder (ADHD), longer-term clinical, comorbidity and self-regulation outcomes are less systematically studied. The aim of this largest NF follow-up to date was to evaluate these outcomes 6 months after NF compared to a semi-active control to disentangle specific from unspecific sustained effects. We performed a multicenter, randomized, parallel, controlled, clinical, superiority trial in five German university outpatient departments. Participants were eligible if they fulfilled DSM-IV-TR criteria for ADHD and were aged from 7 to 9 years. Participants were randomly assigned (1:1-ratio) to 25 sessions of slow cortical potential (SCP)-NF or electromyogram biofeedback (EMG-BF). Participants were not blinded, since they received instructions according to each treatment setting. Primary outcomes were parent ratings of ADHD. The trial was registered, number ISRCTN761871859. Both groups showed improvement of ADHD symptoms compared to baseline at 6-months follow-up with large effect sizes for SCP-NF (d = 1.04) and EMG-BF (d = 0.85), but without group differences. When analyzing all assessments (pre-test, post-test-1, post-test-2 and follow-up), a group-by-time interaction emerged (p = 0.0062), with SCP-NF showing stable improvement following treatment but EMG-BF showing a relapse from post-test-1 to post-test-2, and subsequent remission at follow-up. Six months after the end of treatment, improvement after SCP-NF remained large and stable. However, the lack of group differences at follow-up suggests shared specific and unspecific effects contributing to this clinical outcome. Our correlational results indicate specificity of SCP-NF for selected subscales after training, but not at follow-up. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of European Child & Adolescent Psychiatry is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=137848991
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00787-018-01271-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 1087
    Subjects:
      – SubjectFull: Treatment of attention-deficit hyperactivity disorder
        Type: general
      – SubjectFull: Brain physiology
        Type: general
      – SubjectFull: Attention-deficit hyperactivity disorder
        Type: general
      – SubjectFull: Physiological control systems
        Type: general
      – SubjectFull: Electromyography
        Type: general
      – SubjectFull: Evoked potentials (Electrophysiology)
        Type: general
      – SubjectFull: Medical cooperation
        Type: general
      – SubjectFull: Classification of mental disorders
        Type: general
      – SubjectFull: Research
        Type: general
      – SubjectFull: Self-management (Psychology)
        Type: general
      – SubjectFull: Comorbidity
        Type: general
      – SubjectFull: Disease relapse
        Type: general
      – SubjectFull: Effect sizes (Statistics)
        Type: general
      – SubjectFull: Randomized controlled trials
        Type: general
      – SubjectFull: Treatment effectiveness
        Type: general
      – SubjectFull: Pre-tests & post-tests
        Type: general
      – SubjectFull: Children
        Type: general
      – SubjectFull: Germany
        Type: general
    Titles:
      – TitleFull: Slow cortical potentials neurofeedback in children with ADHD: comorbidity, self-regulation and clinical outcomes 6 months after treatment in a multicenter randomized controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Aggensteiner, Pascal-M.
      – PersonEntity:
          Name:
            NameFull: Brandeis, D.
      – PersonEntity:
          Name:
            NameFull: Millenet, S.
      – PersonEntity:
          Name:
            NameFull: Hohmann, S.
      – PersonEntity:
          Name:
            NameFull: Ruckes, C.
      – PersonEntity:
          Name:
            NameFull: Beuth, S.
      – PersonEntity:
          Name:
            NameFull: Albrecht, B.
      – PersonEntity:
          Name:
            NameFull: Schmitt, G.
      – PersonEntity:
          Name:
            NameFull: Schermuly, S.
      – PersonEntity:
          Name:
            NameFull: Wörz, S.
      – PersonEntity:
          Name:
            NameFull: Gevensleben, H.
      – PersonEntity:
          Name:
            NameFull: Freitag, C. M.
      – PersonEntity:
          Name:
            NameFull: Banaschewski, T.
      – PersonEntity:
          Name:
            NameFull: Rothenberger, A.
      – PersonEntity:
          Name:
            NameFull: Strehl, U.
      – PersonEntity:
          Name:
            NameFull: Holtmann, M.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: Aug2019
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-print
              Value: 10188827
          Numbering:
            – Type: volume
              Value: 28
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: European Child & Adolescent Psychiatry
              Type: main
ResultId 1